Brunei Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Health Wire.

Press releases published on July 30, 2026

an hour ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Indeterminate GlobeNewswire

an hour ago

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

an hour ago

Regeneron Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

an hour ago

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Indeterminate GlobeNewswire

2 hours ago

Amneal Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

3 hours ago

Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027

Indeterminate GlobeNewswire

5 hours ago

Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman

Indeterminate GlobeNewswire

5 hours ago

Relation unveils MORGAN, the next-generation model of cellular biology

Indeterminate GlobeNewswire

5 hours ago

Relation Announces Expanded Collaboration with GSK

Indeterminate GlobeNewswire

5 hours ago

AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa

Indeterminate GlobeNewswire

6 hours ago

Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine

Indeterminate GlobeNewswire

6 hours ago

Sugar Reset Drops Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026

Indeterminate GlobeNewswire

6 hours ago

Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded

Indeterminate GlobeNewswire

6 hours ago

Communiqué de presse : T2 2026 : croissance à deux chiffres du chiffre d’affaires et forte progression du BNPA ; révision à la hausse des perspectives 2026

Indeterminate GlobeNewswire

7 hours ago

Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

Indeterminate GlobeNewswire

7 hours ago

Ipsen réalise d’excellents résultats au premier semestre 2026 et relève ses objectifs financiers annuels

Indeterminate GlobeNewswire

7 hours ago

Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

Indeterminate GlobeNewswire

7 hours ago

HorseFil Confirms Its Official Website and 2026 Package Pricing Amid Similarly Named Sites

Indeterminate GlobeNewswire

7 hours ago

Quantum BioPharma Announces Closing of Debt Settlement

Indeterminate GlobeNewswire

9 hours ago

Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas

Indeterminate GlobeNewswire